LNSR logo

LNSR LENSAR Inc

NASDAQ · Medical - Devices · Healthcare

$4.46
-0.18 (-3.88%)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies desi…

Market Cap: $54.83Mwww.lensar.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
50
4 mentions
—
60d
50
4 mentions
—
90d
50
4 mentions
—
news: 4

Analyst Ratings

3 analysts
Buyconsensus
Strong Buy 0Buy 2Hold 1Sell 0Strong Sell 0
Avg price target$11+146.6%
Low $9Median $11High $13
Current Consensus

Revenue

$14.13M+101.87%
$5.05M$8.94M$12.84M$16.73M
Mar 2019Sep 2026

Analyst Estimates

FY2025
$-2.81
$-3.10–$-2.60
1 analysts
FY2026
$-0.12
$-0.13–$-0.11
1 analysts
FY2027
$-0.31
$-0.34–$-0.29
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Nicholas T. Curtis
Sector
Healthcare
Industry
Medical - Devices
Employees
150
Beta
1.03
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
0.66
www.lensar.com